These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 721835)
41. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation. Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221 [TBL] [Abstract][Full Text] [Related]
42. [Immunology of viral infections]. Kosiakov PN Vestn Akad Med Nauk SSSR; 1983; (12):53-8. PubMed ID: 6198814 [No Abstract] [Full Text] [Related]
43. Use of single radial haemolysis for assessing antibody response to influenza virus vaccines in animals. Smith TL; Jennings R; Potter CW Med Microbiol Immunol; 1987; 176(6):329-39. PubMed ID: 3323861 [TBL] [Abstract][Full Text] [Related]
44. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Chun S; Li C; Van Domselaar G; Wang J; Farnsworth A; Cui X; Rode H; Cyr TD; He R; Li X Vaccine; 2008 Nov; 26(48):6068-76. PubMed ID: 19007587 [TBL] [Abstract][Full Text] [Related]
45. [Evaluation of an inactivated, adjuvated vaccine against swine influenza (author's transl)]. Gourreau JM; Hannoun C; Kaiser C Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):147-53. PubMed ID: 7471706 [No Abstract] [Full Text] [Related]
46. [The immunological shifts in the blood sera of persons inoculated with influenza vaccines]. Stepanovskaia LD; Solomko RM; Avratinskiĭ IM; Katuntsevskaia GP; Kiriliuk ZhI; Iampol'skiĭ MP; Burdeniuk EI Mikrobiol Zh (1978); 1992; 54(4):70-5. PubMed ID: 1406385 [TBL] [Abstract][Full Text] [Related]
47. Antigenic activity of a synthetic peptide comprising the "loop" region of influenza virus hemagglutinin. Jackson DC; Murray JM; White DO; Fagan CN; Tregear GW Virology; 1982 Jul; 120(1):273-6. PubMed ID: 6179292 [No Abstract] [Full Text] [Related]
48. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections. Johansson BE; Kilbourne ED J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790 [TBL] [Abstract][Full Text] [Related]
49. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Russell SM; Liew FY Nature; 1979 Jul; 280(5718):147-8. PubMed ID: 317881 [No Abstract] [Full Text] [Related]
50. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Wesley RD; Lager KM Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702 [TBL] [Abstract][Full Text] [Related]
51. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975 [TBL] [Abstract][Full Text] [Related]
52. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411 [TBL] [Abstract][Full Text] [Related]
53. [The formation of an immune response in volunteers inoculated with a live recombinant influenza vaccine]. Vorob'ev KV; Rudenko LG; Islamova IT; Grigor'eva EP; Egorov AIu; Ermachenko TA; Chepik EB; Zakharova NG; Karachentsev AM Vopr Virusol; 1991; 36(6):475-7. PubMed ID: 1785182 [TBL] [Abstract][Full Text] [Related]
54. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses. Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747 [TBL] [Abstract][Full Text] [Related]
55. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus]. Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000 [TBL] [Abstract][Full Text] [Related]
56. [Isolation of strain-specific and cross-reacting antibodies to influenza virus hemagglutinins from heterogenous populations of hyperimmune influenza sera]. Platonova AL; Isaeva EI; Rovnova ZI Vopr Virusol; 1981; (4):463-6. PubMed ID: 6171102 [TBL] [Abstract][Full Text] [Related]
57. [Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity]. Ismaĭlova IM; Isaeva EI; Rovnova ZI Vopr Virusol; 1985; 30(1):115-9. PubMed ID: 2581366 [No Abstract] [Full Text] [Related]
58. Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. Nicholson KG; Tyrrell DA; Harrison P; Potter CW; Jennings R; Clark A; Schild GC; Wood JM; Yetts R; Seagroatt V; Huggins A; Anderson SG J Biol Stand; 1979 Apr; 7(2):123-36. PubMed ID: 479199 [No Abstract] [Full Text] [Related]
59. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804 [No Abstract] [Full Text] [Related]
60. [Determination of the antigenic composition of the hemagglutinins of influenza viruses H1N1]. Isaeva EI; Rovnova ZI Vopr Virusol; 1983; 28(4):24-9. PubMed ID: 6356600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]